Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

GLMDGLMD
8 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in GALMED PHARMACEUTICALS LTD

WELLS FARGO & COMPANY/MN holds 43 shares of GLMD (GALMED PHARMACEUTICALS LTD), worth $24 as of 2026-Q2.

Current Value

$24

Current Shares

43

Total Value Change

-$99

Total Shares Change

+25

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
43
0.0%
$240.0%$0.56
0
2026-Q1
Increased
43
+377.8%
$210.0%$0.49
12
2025-Q4
Unchanged
9
0.0%
$70.0%$0.75
0
2025-Q3
Unchanged
9
0.0%
$120.0%$1.38
0
2025-Q2
Unchanged
9
0.0%
$170.0%$1.84
0
2025-Q1
Decreased
9
-50.0%
$130.0%$1.44
0
2024-Q4
Unchanged
18
0.0%
$570.0%$3.19
0
2024-Q3
New
18
-
$1230.0%$6.86
17

Other major holders of GLMD: TWO SIGMA INVESTMENTS, LP, Schonfeld Strategic Advisors LLC, CITADEL ADVISORS LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used